These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33445173)

  • 1. Medium Cut-Off Dialysis Membranes: Can They Have Impact on Outcome of COVID-19 Hemodialysis Patients?
    Yalın SF; Altıparmak MR; Dincer MT; Yadigar S; Murt A; Parmaksiz E; Ronco C
    Blood Purif; 2021; 50(6):921-924. PubMed ID: 33445173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium Cut-Off versus Low-Flux Dialyzers in Hemodialysis Patients with COVID-19: Clinical Outcomes and Reduction in Interleukin-6.
    Pongsittisak W; Satpanich P; Jaturapisanukul S; Keawvichit R; Prommool S; Trakranvanich T; Ngamvichukorn T; Kurathong S
    Blood Purif; 2023; 52(6):591-599. PubMed ID: 37231799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of hemodialysis with novel medium cut-off dialyzers.
    Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
    Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
    Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
    Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Medium Cut-Off Dialyzers on Patient-Reported Outcomes: COREXH Registry.
    Alarcon JC; Bunch A; Ardila F; Zuñiga E; Vesga JI; Rivera A; Sánchez R; Sanabria RM;
    Blood Purif; 2021; 50(1):110-118. PubMed ID: 33176299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
    Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
    PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorbing filter AN69 surface treatment in critically ill COVID-19 patients: a single-center experience.
    Chen G; Ma J; Xia P; Hu Y; Liu Z; Zhou X; Li T; Yan X; Chen L; Li X; Qin Y; Zhang S
    Ren Fail; 2021 Dec; 43(1):1492-1495. PubMed ID: 34751601
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Hemodialysis with Medium Cut-Off versus High-Flux Membranes on Endothelial Function of Patients with Chronic Kidney Disease.
    Armani RG; Carvalho AB; Vercia Rocha E Silva M; Verardino R; Bortolotto L; Canziani MEF
    Blood Purif; 2024; 53(7):565-573. PubMed ID: 38330931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.
    Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC
    BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
    Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
    Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
    Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
    Blood Purif; 2020; 49(4):468-478. PubMed ID: 31968346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuations in Interleukin-6 Levels during Hemodialysis Sessions with Medium Cutoff Membranes: An Analysis on COVID-19 Case Series.
    Murt A; Yalin SF; Konukoglu D; Ronco C; Altiparmak MR
    Blood Purif; 2022; 51(11):953-958. PubMed ID: 35176735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China.
    Xiang H; Song B; Zhang Y; Zhang J; Xiong J
    Aging (Albany NY); 2021 Apr; 13(7):9243-9252. PubMed ID: 33811755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring.
    Silva MVR; Carvalho AB; Manfredi SR; Cassiolato JL; Canziani MEF
    Artif Organs; 2024 May; 48(5):433-443. PubMed ID: 38409907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
    Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
    Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone.
    García-Hernández R; Espigares-López MI; Miralles-Aguiar F; Gámiz-Sánchez R; Arroyo Fernández FJ; Pernia Romero A; Torres LM; Calderón Seoane E;
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Feb; 68(2):107-112. PubMed ID: 33455739
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
    Herič T; Vivoda T; Bogataj Š; Pajek J
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19.
    Guo J; Xia H; Wang S; Yu L; Zhang H; Chen J; Shi D; Chen Y; Zhang Y; Xu K; Xu X; Sheng J; Qiu Y; Li L
    Front Immunol; 2020; 11():586073. PubMed ID: 33424838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.